nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—breast cancer—colon cancer	0.501	1	CtDrD
Lapatinib—EGFR—colon cancer	0.228	0.767	CbGaD
Lapatinib—ABCB1—colon cancer	0.0692	0.233	CbGaD
Lapatinib—CYP3A5—Irinotecan—colon cancer	0.0125	0.196	CbGbCtD
Lapatinib—CYP2C8—Fluorouracil—colon cancer	0.0116	0.181	CbGbCtD
Lapatinib—CYP3A5—Vincristine—colon cancer	0.011	0.172	CbGbCtD
Lapatinib—ABCB1—Irinotecan—colon cancer	0.00816	0.128	CbGbCtD
Lapatinib—ABCB1—Vincristine—colon cancer	0.00713	0.112	CbGbCtD
Lapatinib—CYP3A4—Irinotecan—colon cancer	0.00489	0.0766	CbGbCtD
Lapatinib—ABCB1—Methotrexate—colon cancer	0.00432	0.0676	CbGbCtD
Lapatinib—CYP3A4—Vincristine—colon cancer	0.00427	0.0669	CbGbCtD
Lapatinib—ERBB2—gall bladder—colon cancer	0.00217	0.0739	CbGeAlD
Lapatinib—Cardiotoxicity—Fluorouracil—colon cancer	0.00173	0.0462	CcSEcCtD
Lapatinib—ERBB2—embryo—colon cancer	0.00137	0.0468	CbGeAlD
Lapatinib—ERBB4—embryo—colon cancer	0.00137	0.0468	CbGeAlD
Lapatinib—Paronychia—Methotrexate—colon cancer	0.00122	0.0326	CcSEcCtD
Lapatinib—ERBB2—epithelium—colon cancer	0.00112	0.0382	CbGeAlD
Lapatinib—ERBB4—epithelium—colon cancer	0.00112	0.0382	CbGeAlD
Lapatinib—ERBB2—smooth muscle tissue—colon cancer	0.00108	0.0368	CbGeAlD
Lapatinib—TAP1—bone marrow—colon cancer	0.00108	0.0367	CbGeAlD
Lapatinib—ERBB2—renal system—colon cancer	0.00104	0.0355	CbGeAlD
Lapatinib—TAP1—vagina—colon cancer	0.00103	0.0352	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—colon cancer	0.00101	0.0345	CbGeAlD
Lapatinib—PIK3C2B—bone marrow—colon cancer	0.00101	0.0345	CbGeAlD
Lapatinib—Peripheral sensory neuropathy—Capecitabine—colon cancer	0.000995	0.0266	CcSEcCtD
Lapatinib—Gefitinib—EGFR—colon cancer	0.000976	0.767	CrCbGaD
Lapatinib—PI4KB—renal system—colon cancer	0.000973	0.0332	CbGeAlD
Lapatinib—PIK3C2B—vagina—colon cancer	0.000968	0.033	CbGeAlD
Lapatinib—TAP1—liver—colon cancer	0.00087	0.0297	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—colon cancer	0.000863	0.0294	CbGeAlD
Lapatinib—ERBB2—digestive system—colon cancer	0.000852	0.0291	CbGeAlD
Lapatinib—PIK3C2B—liver—colon cancer	0.000817	0.0279	CbGeAlD
Lapatinib—Mucosal inflammation—Irinotecan—colon cancer	0.000767	0.0205	CcSEcCtD
Lapatinib—PIK3C2B—Topotecan—Irinotecan—colon cancer	0.000759	0.303	CbGdCrCtD
Lapatinib—ERBB4—vagina—colon cancer	0.000753	0.0257	CbGeAlD
Lapatinib—PI4KB—bone marrow—colon cancer	0.000736	0.0251	CbGeAlD
Lapatinib—PI4KB—vagina—colon cancer	0.000705	0.0241	CbGeAlD
Lapatinib—TAP1—lymph node—colon cancer	0.000667	0.0228	CbGeAlD
Lapatinib—ERBB2—liver—colon cancer	0.000635	0.0217	CbGeAlD
Lapatinib—Nail disorder—Fluorouracil—colon cancer	0.000627	0.0168	CcSEcCtD
Lapatinib—PIK3C2B—lymph node—colon cancer	0.000626	0.0214	CbGeAlD
Lapatinib—ERBB2—Topotecan—Irinotecan—colon cancer	0.000625	0.25	CbGdCrCtD
Lapatinib—PI4KB—liver—colon cancer	0.000595	0.0203	CbGeAlD
Lapatinib—PIK3C2B—Vindesine—Vincristine—colon cancer	0.000542	0.217	CbGdCrCtD
Lapatinib—EGFR—liver—colon cancer	0.000538	0.0184	CbGeAlD
Lapatinib—Mucosal inflammation—Capecitabine—colon cancer	0.000513	0.0137	CcSEcCtD
Lapatinib—Neoplasm malignant—Irinotecan—colon cancer	0.000497	0.0133	CcSEcCtD
Lapatinib—ERBB2—lymph node—colon cancer	0.000487	0.0166	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Irinotecan—colon cancer	0.000467	0.0125	CcSEcCtD
Lapatinib—PI4KB—lymph node—colon cancer	0.000456	0.0156	CbGeAlD
Lapatinib—Blood bilirubin increased—Irinotecan—colon cancer	0.000449	0.012	CcSEcCtD
Lapatinib—Nail disorder—Capecitabine—colon cancer	0.000438	0.0117	CcSEcCtD
Lapatinib—Haemoglobin decreased—Capecitabine—colon cancer	0.000413	0.0111	CcSEcCtD
Lapatinib—EGFR—lymph node—colon cancer	0.000413	0.0141	CbGeAlD
Lapatinib—Mucosal inflammation—Methotrexate—colon cancer	0.000382	0.0102	CcSEcCtD
Lapatinib—Hepatotoxicity—Capecitabine—colon cancer	0.000368	0.00985	CcSEcCtD
Lapatinib—PIK3C2B—Vinorelbine—Vincristine—colon cancer	0.000342	0.137	CbGdCrCtD
Lapatinib—Renal failure acute—Irinotecan—colon cancer	0.000334	0.00894	CcSEcCtD
Lapatinib—Nail disorder—Methotrexate—colon cancer	0.000326	0.00873	CcSEcCtD
Lapatinib—Pain in extremity—Vincristine—colon cancer	0.000317	0.00847	CcSEcCtD
Lapatinib—Hyperbilirubinaemia—Capecitabine—colon cancer	0.000313	0.00837	CcSEcCtD
Lapatinib—Cardiac failure—Fluorouracil—colon cancer	0.000303	0.0081	CcSEcCtD
Lapatinib—Blood bilirubin increased—Capecitabine—colon cancer	0.000301	0.00804	CcSEcCtD
Lapatinib—ABCB1—blood vessel—colon cancer	0.0003	0.0102	CbGeAlD
Lapatinib—Interstitial lung disease—Methotrexate—colon cancer	0.000299	0.008	CcSEcCtD
Lapatinib—Gefitinib—ABCB1—colon cancer	0.000297	0.233	CrCbGaD
Lapatinib—Dehydration—Vincristine—colon cancer	0.000294	0.00788	CcSEcCtD
Lapatinib—Dehydration—Irinotecan—colon cancer	0.000287	0.00767	CcSEcCtD
Lapatinib—CYP2C8—renal system—colon cancer	0.000282	0.00964	CbGeAlD
Lapatinib—Hepatotoxicity—Methotrexate—colon cancer	0.000274	0.00733	CcSEcCtD
Lapatinib—Dry skin—Fluorouracil—colon cancer	0.000271	0.00724	CcSEcCtD
Lapatinib—CYP2C19—digestive system—colon cancer	0.000265	0.00905	CbGeAlD
Lapatinib—Neutropenia—Vincristine—colon cancer	0.000256	0.00685	CcSEcCtD
Lapatinib—CYP3A5—renal system—colon cancer	0.000255	0.0087	CbGeAlD
Lapatinib—Neutropenia—Irinotecan—colon cancer	0.000249	0.00667	CcSEcCtD
Lapatinib—Pneumonia—Vincristine—colon cancer	0.000245	0.00657	CcSEcCtD
Lapatinib—Neuropathy peripheral—Vincristine—colon cancer	0.000239	0.0064	CcSEcCtD
Lapatinib—Pneumonia—Irinotecan—colon cancer	0.000239	0.0064	CcSEcCtD
Lapatinib—Stomatitis—Vincristine—colon cancer	0.000238	0.00636	CcSEcCtD
Lapatinib—PIK3C2B—Vinblastine—Vincristine—colon cancer	0.000235	0.094	CbGdCrCtD
Lapatinib—CYP2C19—vagina—colon cancer	0.000234	0.008	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Methotrexate—colon cancer	0.000233	0.00623	CcSEcCtD
Lapatinib—Stomatitis—Irinotecan—colon cancer	0.000232	0.0062	CcSEcCtD
Lapatinib—Pneumonia—Fluorouracil—colon cancer	0.000229	0.00612	CcSEcCtD
Lapatinib—Infestation NOS—Fluorouracil—colon cancer	0.000228	0.00609	CcSEcCtD
Lapatinib—Infestation—Fluorouracil—colon cancer	0.000228	0.00609	CcSEcCtD
Lapatinib—Renal failure acute—Capecitabine—colon cancer	0.000223	0.00598	CcSEcCtD
Lapatinib—Neuropathy peripheral—Fluorouracil—colon cancer	0.000223	0.00597	CcSEcCtD
Lapatinib—Stomatitis—Fluorouracil—colon cancer	0.000222	0.00594	CcSEcCtD
Lapatinib—Hot flush—Capecitabine—colon cancer	0.000221	0.0059	CcSEcCtD
Lapatinib—Menopausal symptoms—Capecitabine—colon cancer	0.000219	0.00585	CcSEcCtD
Lapatinib—Connective tissue disorder—Vincristine—colon cancer	0.000215	0.00576	CcSEcCtD
Lapatinib—Epistaxis—Fluorouracil—colon cancer	0.000215	0.00574	CcSEcCtD
Lapatinib—Cardiac failure—Capecitabine—colon cancer	0.000211	0.00566	CcSEcCtD
Lapatinib—Connective tissue disorder—Irinotecan—colon cancer	0.00021	0.00561	CcSEcCtD
Lapatinib—CYP3A5—digestive system—colon cancer	0.000209	0.00713	CbGeAlD
Lapatinib—Pain in extremity—Capecitabine—colon cancer	0.000206	0.00552	CcSEcCtD
Lapatinib—CYP2C8—vagina—colon cancer	0.000205	0.00698	CbGeAlD
Lapatinib—Cardiac disorder—Vincristine—colon cancer	0.000203	0.00544	CcSEcCtD
Lapatinib—Angiopathy—Vincristine—colon cancer	0.000199	0.00532	CcSEcCtD
Lapatinib—Cardiac disorder—Irinotecan—colon cancer	0.000198	0.0053	CcSEcCtD
Lapatinib—CYP2C19—liver—colon cancer	0.000198	0.00675	CbGeAlD
Lapatinib—Mediastinal disorder—Vincristine—colon cancer	0.000197	0.00528	CcSEcCtD
Lapatinib—Alopecia—Vincristine—colon cancer	0.000194	0.00518	CcSEcCtD
Lapatinib—Angiopathy—Irinotecan—colon cancer	0.000194	0.00518	CcSEcCtD
Lapatinib—Immune system disorder—Irinotecan—colon cancer	0.000193	0.00516	CcSEcCtD
Lapatinib—Mediastinal disorder—Irinotecan—colon cancer	0.000192	0.00514	CcSEcCtD
Lapatinib—Dehydration—Capecitabine—colon cancer	0.000192	0.00514	CcSEcCtD
Lapatinib—Mental disorder—Vincristine—colon cancer	0.000192	0.00513	CcSEcCtD
Lapatinib—CYP3A4—renal system—colon cancer	0.000191	0.00653	CbGeAlD
Lapatinib—Dry skin—Capecitabine—colon cancer	0.000189	0.00506	CcSEcCtD
Lapatinib—Alopecia—Irinotecan—colon cancer	0.000188	0.00504	CcSEcCtD
Lapatinib—CYP3A5—vagina—colon cancer	0.000185	0.0063	CbGeAlD
Lapatinib—Back pain—Vincristine—colon cancer	0.000184	0.00494	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000182	0.00487	CcSEcCtD
Lapatinib—Alopecia—Fluorouracil—colon cancer	0.000181	0.00483	CcSEcCtD
Lapatinib—Back pain—Irinotecan—colon cancer	0.00018	0.00481	CcSEcCtD
Lapatinib—ABCB1—embryo—colon cancer	0.000179	0.0061	CbGeAlD
Lapatinib—Anaemia—Vincristine—colon cancer	0.000176	0.00472	CcSEcCtD
Lapatinib—CYP2C8—liver—colon cancer	0.000173	0.00589	CbGeAlD
Lapatinib—Anaemia—Irinotecan—colon cancer	0.000172	0.00459	CcSEcCtD
Lapatinib—Leukopenia—Vincristine—colon cancer	0.000171	0.00457	CcSEcCtD
Lapatinib—Neutropenia—Capecitabine—colon cancer	0.000167	0.00446	CcSEcCtD
Lapatinib—Renal failure acute—Methotrexate—colon cancer	0.000166	0.00445	CcSEcCtD
Lapatinib—Leukopenia—Irinotecan—colon cancer	0.000166	0.00445	CcSEcCtD
Lapatinib—Anaemia—Fluorouracil—colon cancer	0.000164	0.0044	CcSEcCtD
Lapatinib—Myalgia—Vincristine—colon cancer	0.000162	0.00434	CcSEcCtD
Lapatinib—Cough—Irinotecan—colon cancer	0.000162	0.00434	CcSEcCtD
Lapatinib—Pneumonia—Capecitabine—colon cancer	0.00016	0.00428	CcSEcCtD
Lapatinib—Leukopenia—Fluorouracil—colon cancer	0.000159	0.00426	CcSEcCtD
Lapatinib—Infestation—Capecitabine—colon cancer	0.000159	0.00426	CcSEcCtD
Lapatinib—Infestation NOS—Capecitabine—colon cancer	0.000159	0.00426	CcSEcCtD
Lapatinib—CYP3A4—digestive system—colon cancer	0.000157	0.00535	CbGeAlD
Lapatinib—Neuropathy peripheral—Capecitabine—colon cancer	0.000156	0.00417	CcSEcCtD
Lapatinib—CYP3A5—liver—colon cancer	0.000156	0.00531	CbGeAlD
Lapatinib—Anaphylactic shock—Vincristine—colon cancer	0.000156	0.00416	CcSEcCtD
Lapatinib—Stomatitis—Capecitabine—colon cancer	0.000155	0.00415	CcSEcCtD
Lapatinib—Infection—Vincristine—colon cancer	0.000155	0.00414	CcSEcCtD
Lapatinib—Nervous system disorder—Vincristine—colon cancer	0.000153	0.00408	CcSEcCtD
Lapatinib—Anaphylactic shock—Irinotecan—colon cancer	0.000152	0.00406	CcSEcCtD
Lapatinib—Myalgia—Fluorouracil—colon cancer	0.000151	0.00405	CcSEcCtD
Lapatinib—Infection—Irinotecan—colon cancer	0.000151	0.00403	CcSEcCtD
Lapatinib—Hepatobiliary disease—Capecitabine—colon cancer	0.00015	0.00402	CcSEcCtD
Lapatinib—Epistaxis—Capecitabine—colon cancer	0.00015	0.00401	CcSEcCtD
Lapatinib—Nervous system disorder—Irinotecan—colon cancer	0.000149	0.00398	CcSEcCtD
Lapatinib—Anorexia—Vincristine—colon cancer	0.000148	0.00397	CcSEcCtD
Lapatinib—ABCB1—epithelium—colon cancer	0.000146	0.00498	CbGeAlD
Lapatinib—Anaphylactic shock—Fluorouracil—colon cancer	0.000145	0.00388	CcSEcCtD
Lapatinib—Anorexia—Irinotecan—colon cancer	0.000144	0.00387	CcSEcCtD
Lapatinib—Infection—Fluorouracil—colon cancer	0.000144	0.00386	CcSEcCtD
Lapatinib—Nervous system disorder—Fluorouracil—colon cancer	0.000142	0.00381	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Vincristine—colon cancer	0.000142	0.00379	CcSEcCtD
Lapatinib—Insomnia—Vincristine—colon cancer	0.000141	0.00377	CcSEcCtD
Lapatinib—Connective tissue disorder—Capecitabine—colon cancer	0.00014	0.00375	CcSEcCtD
Lapatinib—Anorexia—Fluorouracil—colon cancer	0.000138	0.0037	CcSEcCtD
Lapatinib—Insomnia—Irinotecan—colon cancer	0.000137	0.00367	CcSEcCtD
Lapatinib—ABCB1—renal system—colon cancer	0.000135	0.00462	CbGeAlD
Lapatinib—Decreased appetite—Vincristine—colon cancer	0.000135	0.00362	CcSEcCtD
Lapatinib—Dyspnoea—Irinotecan—colon cancer	0.000135	0.00362	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Vincristine—colon cancer	0.000134	0.00359	CcSEcCtD
Lapatinib—Fatigue—Vincristine—colon cancer	0.000134	0.00359	CcSEcCtD
Lapatinib—Dyspepsia—Irinotecan—colon cancer	0.000133	0.00357	CcSEcCtD
Lapatinib—Constipation—Vincristine—colon cancer	0.000133	0.00356	CcSEcCtD
Lapatinib—Cardiac disorder—Capecitabine—colon cancer	0.000132	0.00355	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000132	0.00354	CcSEcCtD
Lapatinib—Decreased appetite—Irinotecan—colon cancer	0.000132	0.00353	CcSEcCtD
Lapatinib—Insomnia—Fluorouracil—colon cancer	0.000131	0.00351	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Irinotecan—colon cancer	0.000131	0.0035	CcSEcCtD
Lapatinib—Fatigue—Irinotecan—colon cancer	0.000131	0.0035	CcSEcCtD
Lapatinib—Constipation—Irinotecan—colon cancer	0.00013	0.00347	CcSEcCtD
Lapatinib—Angiopathy—Capecitabine—colon cancer	0.00013	0.00347	CcSEcCtD
Lapatinib—Dyspnoea—Fluorouracil—colon cancer	0.000129	0.00346	CcSEcCtD
Lapatinib—Immune system disorder—Capecitabine—colon cancer	0.000129	0.00345	CcSEcCtD
Lapatinib—Mediastinal disorder—Capecitabine—colon cancer	0.000129	0.00344	CcSEcCtD
Lapatinib—Dyspepsia—Fluorouracil—colon cancer	0.000128	0.00342	CcSEcCtD
Lapatinib—Gastrointestinal pain—Vincristine—colon cancer	0.000127	0.0034	CcSEcCtD
Lapatinib—Decreased appetite—Fluorouracil—colon cancer	0.000126	0.00338	CcSEcCtD
Lapatinib—Alopecia—Capecitabine—colon cancer	0.000126	0.00338	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000125	0.00335	CcSEcCtD
Lapatinib—Mental disorder—Capecitabine—colon cancer	0.000125	0.00335	CcSEcCtD
Lapatinib—Malnutrition—Capecitabine—colon cancer	0.000124	0.00333	CcSEcCtD
Lapatinib—Neutropenia—Methotrexate—colon cancer	0.000124	0.00332	CcSEcCtD
Lapatinib—Gastrointestinal pain—Irinotecan—colon cancer	0.000124	0.00332	CcSEcCtD
Lapatinib—Abdominal pain—Vincristine—colon cancer	0.000123	0.00329	CcSEcCtD
Lapatinib—Back pain—Capecitabine—colon cancer	0.00012	0.00322	CcSEcCtD
Lapatinib—Abdominal pain—Irinotecan—colon cancer	0.00012	0.00321	CcSEcCtD
Lapatinib—Pneumonia—Methotrexate—colon cancer	0.000119	0.00319	CcSEcCtD
Lapatinib—Infestation—Methotrexate—colon cancer	0.000118	0.00317	CcSEcCtD
Lapatinib—Infestation NOS—Methotrexate—colon cancer	0.000118	0.00317	CcSEcCtD
Lapatinib—CYP3A4—liver—colon cancer	0.000117	0.00399	CbGeAlD
Lapatinib—Stomatitis—Methotrexate—colon cancer	0.000115	0.00309	CcSEcCtD
Lapatinib—Anaemia—Capecitabine—colon cancer	0.000115	0.00307	CcSEcCtD
Lapatinib—Hypersensitivity—Vincristine—colon cancer	0.000115	0.00307	CcSEcCtD
Lapatinib—ABCB1—lymphoid tissue—colon cancer	0.000112	0.00384	CbGeAlD
Lapatinib—Hepatobiliary disease—Methotrexate—colon cancer	0.000112	0.003	CcSEcCtD
Lapatinib—Epistaxis—Methotrexate—colon cancer	0.000112	0.00299	CcSEcCtD
Lapatinib—Hypersensitivity—Irinotecan—colon cancer	0.000112	0.00299	CcSEcCtD
Lapatinib—Asthenia—Vincristine—colon cancer	0.000112	0.00299	CcSEcCtD
Lapatinib—Leukopenia—Capecitabine—colon cancer	0.000111	0.00298	CcSEcCtD
Lapatinib—ABCB1—digestive system—colon cancer	0.000111	0.00379	CbGeAlD
Lapatinib—Palpitations—Capecitabine—colon cancer	0.00011	0.00294	CcSEcCtD
Lapatinib—Asthenia—Irinotecan—colon cancer	0.000109	0.00291	CcSEcCtD
Lapatinib—Cough—Capecitabine—colon cancer	0.000108	0.0029	CcSEcCtD
Lapatinib—Hypersensitivity—Fluorouracil—colon cancer	0.000107	0.00286	CcSEcCtD
Lapatinib—Diarrhoea—Vincristine—colon cancer	0.000106	0.00285	CcSEcCtD
Lapatinib—Myalgia—Capecitabine—colon cancer	0.000106	0.00283	CcSEcCtD
Lapatinib—Arthralgia—Capecitabine—colon cancer	0.000106	0.00283	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000105	0.00281	CcSEcCtD
Lapatinib—Diarrhoea—Irinotecan—colon cancer	0.000104	0.00277	CcSEcCtD
Lapatinib—Pruritus—Fluorouracil—colon cancer	0.000103	0.00275	CcSEcCtD
Lapatinib—ABCB1—bone marrow—colon cancer	0.000102	0.00349	CbGeAlD
Lapatinib—Infection—Capecitabine—colon cancer	0.000101	0.0027	CcSEcCtD
Lapatinib—Nervous system disorder—Capecitabine—colon cancer	9.95e-05	0.00266	CcSEcCtD
Lapatinib—Diarrhoea—Fluorouracil—colon cancer	9.93e-05	0.00266	CcSEcCtD
Lapatinib—Vomiting—Vincristine—colon cancer	9.89e-05	0.00265	CcSEcCtD
Lapatinib—Cardiac disorder—Methotrexate—colon cancer	9.86e-05	0.00264	CcSEcCtD
Lapatinib—Skin disorder—Capecitabine—colon cancer	9.85e-05	0.00264	CcSEcCtD
Lapatinib—Rash—Vincristine—colon cancer	9.81e-05	0.00263	CcSEcCtD
Lapatinib—ABCB1—vagina—colon cancer	9.81e-05	0.00335	CbGeAlD
Lapatinib—Dermatitis—Vincristine—colon cancer	9.8e-05	0.00262	CcSEcCtD
Lapatinib—Headache—Vincristine—colon cancer	9.75e-05	0.00261	CcSEcCtD
Lapatinib—Anorexia—Capecitabine—colon cancer	9.67e-05	0.00259	CcSEcCtD
Lapatinib—Angiopathy—Methotrexate—colon cancer	9.64e-05	0.00258	CcSEcCtD
Lapatinib—Vomiting—Irinotecan—colon cancer	9.63e-05	0.00258	CcSEcCtD
Lapatinib—Immune system disorder—Methotrexate—colon cancer	9.6e-05	0.00257	CcSEcCtD
Lapatinib—Mediastinal disorder—Methotrexate—colon cancer	9.58e-05	0.00256	CcSEcCtD
Lapatinib—Rash—Irinotecan—colon cancer	9.55e-05	0.00256	CcSEcCtD
Lapatinib—Dermatitis—Irinotecan—colon cancer	9.55e-05	0.00255	CcSEcCtD
Lapatinib—Headache—Irinotecan—colon cancer	9.49e-05	0.00254	CcSEcCtD
Lapatinib—Alopecia—Methotrexate—colon cancer	9.39e-05	0.00251	CcSEcCtD
Lapatinib—Mental disorder—Methotrexate—colon cancer	9.31e-05	0.00249	CcSEcCtD
Lapatinib—Malnutrition—Methotrexate—colon cancer	9.25e-05	0.00248	CcSEcCtD
Lapatinib—Nausea—Vincristine—colon cancer	9.24e-05	0.00247	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Capecitabine—colon cancer	9.24e-05	0.00247	CcSEcCtD
Lapatinib—Vomiting—Fluorouracil—colon cancer	9.23e-05	0.00247	CcSEcCtD
Lapatinib—Insomnia—Capecitabine—colon cancer	9.17e-05	0.00245	CcSEcCtD
Lapatinib—Rash—Fluorouracil—colon cancer	9.15e-05	0.00245	CcSEcCtD
Lapatinib—Dermatitis—Fluorouracil—colon cancer	9.14e-05	0.00245	CcSEcCtD
Lapatinib—Headache—Fluorouracil—colon cancer	9.09e-05	0.00243	CcSEcCtD
Lapatinib—Dyspnoea—Capecitabine—colon cancer	9.04e-05	0.00242	CcSEcCtD
Lapatinib—Nausea—Irinotecan—colon cancer	9e-05	0.00241	CcSEcCtD
Lapatinib—Back pain—Methotrexate—colon cancer	8.95e-05	0.00239	CcSEcCtD
Lapatinib—Dyspepsia—Capecitabine—colon cancer	8.93e-05	0.00239	CcSEcCtD
Lapatinib—Decreased appetite—Capecitabine—colon cancer	8.82e-05	0.00236	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Capecitabine—colon cancer	8.76e-05	0.00234	CcSEcCtD
Lapatinib—Fatigue—Capecitabine—colon cancer	8.74e-05	0.00234	CcSEcCtD
Lapatinib—Constipation—Capecitabine—colon cancer	8.67e-05	0.00232	CcSEcCtD
Lapatinib—Nausea—Fluorouracil—colon cancer	8.62e-05	0.00231	CcSEcCtD
Lapatinib—Anaemia—Methotrexate—colon cancer	8.55e-05	0.00229	CcSEcCtD
Lapatinib—Gastrointestinal pain—Capecitabine—colon cancer	8.29e-05	0.00222	CcSEcCtD
Lapatinib—Leukopenia—Methotrexate—colon cancer	8.28e-05	0.00222	CcSEcCtD
Lapatinib—ABCB1—liver—colon cancer	8.27e-05	0.00282	CbGeAlD
Lapatinib—Cough—Methotrexate—colon cancer	8.07e-05	0.00216	CcSEcCtD
Lapatinib—Abdominal pain—Capecitabine—colon cancer	8.02e-05	0.00215	CcSEcCtD
Lapatinib—Myalgia—Methotrexate—colon cancer	7.88e-05	0.00211	CcSEcCtD
Lapatinib—Arthralgia—Methotrexate—colon cancer	7.88e-05	0.00211	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	7.82e-05	0.00209	CcSEcCtD
Lapatinib—Anaphylactic shock—Methotrexate—colon cancer	7.55e-05	0.00202	CcSEcCtD
Lapatinib—Infection—Methotrexate—colon cancer	7.5e-05	0.00201	CcSEcCtD
Lapatinib—Hypersensitivity—Capecitabine—colon cancer	7.47e-05	0.002	CcSEcCtD
Lapatinib—Nervous system disorder—Methotrexate—colon cancer	7.4e-05	0.00198	CcSEcCtD
Lapatinib—Skin disorder—Methotrexate—colon cancer	7.33e-05	0.00196	CcSEcCtD
Lapatinib—Asthenia—Capecitabine—colon cancer	7.28e-05	0.00195	CcSEcCtD
Lapatinib—Anorexia—Methotrexate—colon cancer	7.2e-05	0.00193	CcSEcCtD
Lapatinib—Pruritus—Capecitabine—colon cancer	7.17e-05	0.00192	CcSEcCtD
Lapatinib—Diarrhoea—Capecitabine—colon cancer	6.94e-05	0.00186	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methotrexate—colon cancer	6.88e-05	0.00184	CcSEcCtD
Lapatinib—Insomnia—Methotrexate—colon cancer	6.83e-05	0.00183	CcSEcCtD
Lapatinib—Dyspnoea—Methotrexate—colon cancer	6.73e-05	0.0018	CcSEcCtD
Lapatinib—Dyspepsia—Methotrexate—colon cancer	6.65e-05	0.00178	CcSEcCtD
Lapatinib—Decreased appetite—Methotrexate—colon cancer	6.56e-05	0.00176	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Methotrexate—colon cancer	6.52e-05	0.00174	CcSEcCtD
Lapatinib—Fatigue—Methotrexate—colon cancer	6.51e-05	0.00174	CcSEcCtD
Lapatinib—Vomiting—Capecitabine—colon cancer	6.45e-05	0.00173	CcSEcCtD
Lapatinib—Rash—Capecitabine—colon cancer	6.39e-05	0.00171	CcSEcCtD
Lapatinib—Dermatitis—Capecitabine—colon cancer	6.39e-05	0.00171	CcSEcCtD
Lapatinib—Headache—Capecitabine—colon cancer	6.35e-05	0.0017	CcSEcCtD
Lapatinib—ABCB1—lymph node—colon cancer	6.34e-05	0.00216	CbGeAlD
Lapatinib—Gastrointestinal pain—Methotrexate—colon cancer	6.17e-05	0.00165	CcSEcCtD
Lapatinib—Nausea—Capecitabine—colon cancer	6.02e-05	0.00161	CcSEcCtD
Lapatinib—Abdominal pain—Methotrexate—colon cancer	5.97e-05	0.0016	CcSEcCtD
Lapatinib—Hypersensitivity—Methotrexate—colon cancer	5.56e-05	0.00149	CcSEcCtD
Lapatinib—Asthenia—Methotrexate—colon cancer	5.42e-05	0.00145	CcSEcCtD
Lapatinib—Pruritus—Methotrexate—colon cancer	5.34e-05	0.00143	CcSEcCtD
Lapatinib—Diarrhoea—Methotrexate—colon cancer	5.17e-05	0.00138	CcSEcCtD
Lapatinib—Vomiting—Methotrexate—colon cancer	4.8e-05	0.00128	CcSEcCtD
Lapatinib—Rash—Methotrexate—colon cancer	4.76e-05	0.00127	CcSEcCtD
Lapatinib—Dermatitis—Methotrexate—colon cancer	4.76e-05	0.00127	CcSEcCtD
Lapatinib—Headache—Methotrexate—colon cancer	4.73e-05	0.00127	CcSEcCtD
Lapatinib—Nausea—Methotrexate—colon cancer	4.48e-05	0.0012	CcSEcCtD
Lapatinib—ERBB2—Innate Immune System—PIK3CA—colon cancer	1.09e-05	0.000159	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—AKT1—colon cancer	1.09e-05	0.000159	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—AKT1—colon cancer	1.08e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	1.07e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—PIK3CA—colon cancer	1.07e-05	0.000157	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VEGFA—colon cancer	1.07e-05	0.000156	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—NRAS—colon cancer	1.05e-05	0.000154	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.04e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—AKT1—colon cancer	1.04e-05	0.000153	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—PIK3CA—colon cancer	1.04e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.04e-05	0.000152	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—PIK3CA—colon cancer	1.03e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—AKT1—colon cancer	1.02e-05	0.00015	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HRAS—colon cancer	1.01e-05	0.000147	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—AKT1—colon cancer	1.01e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KRAS—colon cancer	1e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDH1—colon cancer	9.94e-06	0.000145	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HRAS—colon cancer	9.91e-06	0.000145	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—AKT1—colon cancer	9.82e-06	0.000144	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	9.79e-06	0.000143	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	9.69e-06	0.000142	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HRAS—colon cancer	9.66e-06	0.000141	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FGFR3—colon cancer	9.54e-06	0.00014	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HRAS—colon cancer	9.51e-06	0.000139	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—colon cancer	9.5e-06	0.000139	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—AKT1—colon cancer	9.49e-06	0.000139	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	9.43e-06	0.000138	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FGFR3—colon cancer	9.4e-06	0.000138	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—colon cancer	9.36e-06	0.000137	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	9.34e-06	0.000137	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—PIK3CA—colon cancer	9.21e-06	0.000135	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CTNNB1—colon cancer	9.21e-06	0.000135	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	9.12e-06	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—KRAS—colon cancer	9.08e-06	0.000133	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CTNNB1—colon cancer	9.07e-06	0.000133	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDKN1A—colon cancer	8.99e-06	0.000132	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—AKT1—colon cancer	8.88e-06	0.00013	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDKN1A—colon cancer	8.86e-06	0.00013	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—APC—colon cancer	8.76e-06	0.000128	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—AKT1—colon cancer	8.75e-06	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—colon cancer	8.72e-06	0.000128	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	8.68e-06	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CTNNB1—colon cancer	8.65e-06	0.000127	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—APC—colon cancer	8.63e-06	0.000126	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EP300—colon cancer	8.56e-06	0.000125	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—AKT1—colon cancer	8.53e-06	0.000125	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—HRAS—colon cancer	8.52e-06	0.000125	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CTNNB1—colon cancer	8.5e-06	0.000124	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	8.44e-06	0.000124	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EP300—colon cancer	8.43e-06	0.000123	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—AKT1—colon cancer	8.4e-06	0.000123	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CTNNB1—colon cancer	8.37e-06	0.000123	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—SRC—colon cancer	8.32e-06	0.000122	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDKN1A—colon cancer	8.3e-06	0.000122	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CHST5—colon cancer	8.27e-06	0.000121	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ODC1—colon cancer	8.27e-06	0.000121	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—BRAF—colon cancer	8.24e-06	0.000121	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	8.22e-06	0.00012	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—SRC—colon cancer	8.2e-06	0.00012	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDKN1A—colon cancer	8.18e-06	0.00012	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—BRAF—colon cancer	8.11e-06	0.000119	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—EP300—colon cancer	8.04e-06	0.000118	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NRAS—colon cancer	8.01e-06	0.000117	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EP300—colon cancer	7.9e-06	0.000116	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NRAS—colon cancer	7.89e-06	0.000115	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—SRC—colon cancer	7.82e-06	0.000114	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EP300—colon cancer	7.78e-06	0.000114	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—HRAS—colon cancer	7.71e-06	0.000113	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SRC—colon cancer	7.68e-06	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CTNNB1—colon cancer	7.64e-06	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—colon cancer	7.62e-06	0.000111	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SRC—colon cancer	7.57e-06	0.000111	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	7.57e-06	0.000111	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	7.55e-06	0.00011	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—AKT1—colon cancer	7.53e-06	0.00011	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NRAS—colon cancer	7.52e-06	0.00011	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CDKN1A—colon cancer	7.47e-06	0.000109	CbGpPWpGaD
Lapatinib—EGFR—Immune System—BCL2L1—colon cancer	7.46e-06	0.000109	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	7.4e-06	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NRAS—colon cancer	7.39e-06	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—colon cancer	7.29e-06	0.000107	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NRAS—colon cancer	7.28e-06	0.000107	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—colon cancer	7.18e-06	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDKN1A—colon cancer	7.17e-06	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FGFR3—colon cancer	7.14e-06	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—EP300—colon cancer	7.1e-06	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—colon cancer	6.99e-06	0.000102	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	6.99e-06	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—SRC—colon cancer	6.91e-06	0.000101	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KRAS—colon cancer	6.89e-06	0.000101	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MYC—colon cancer	6.89e-06	0.000101	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—colon cancer	6.87e-06	0.000101	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KRAS—colon cancer	6.79e-06	9.93e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MYC—colon cancer	6.78e-06	9.92e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—colon cancer	6.77e-06	9.9e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—colon cancer	6.73e-06	9.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NRAS—colon cancer	6.65e-06	9.72e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—colon cancer	6.63e-06	9.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—SRC—colon cancer	6.63e-06	9.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—FGFR3—colon cancer	6.59e-06	9.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—KRAS—colon cancer	6.48e-06	9.48e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.42e-06	9.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NRAS—colon cancer	6.38e-06	9.34e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KRAS—colon cancer	6.36e-06	9.31e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.36e-06	9.31e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—PIK3CA—colon cancer	6.33e-06	9.26e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KRAS—colon cancer	6.27e-06	9.17e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PIK3CA—colon cancer	6.24e-06	9.12e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.21e-06	9.09e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP3—colon cancer	6.18e-06	9.04e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP3—colon cancer	6.08e-06	8.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—APC—colon cancer	6.05e-06	8.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDH1—colon cancer	6.03e-06	8.82e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCND1—colon cancer	6.01e-06	8.8e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CTNNB1—colon cancer	5.95e-06	8.71e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCND1—colon cancer	5.92e-06	8.66e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CTNNB1—colon cancer	5.86e-06	8.58e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—colon cancer	5.86e-06	8.57e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PIK3CA—colon cancer	5.84e-06	8.55e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1A—colon cancer	5.81e-06	8.51e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—colon cancer	5.77e-06	8.44e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PIK3CA—colon cancer	5.76e-06	8.42e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1A—colon cancer	5.73e-06	8.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KRAS—colon cancer	5.72e-06	8.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—BRAF—colon cancer	5.69e-06	8.32e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.68e-06	8.31e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EP300—colon cancer	5.53e-06	8.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—colon cancer	5.5e-06	8.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KRAS—colon cancer	5.49e-06	8.04e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EP300—colon cancer	5.45e-06	7.98e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—colon cancer	5.41e-06	7.91e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SRC—colon cancer	5.38e-06	7.87e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—colon cancer	5.33e-06	7.79e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SRC—colon cancer	5.3e-06	7.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—PIK3CA—colon cancer	5.25e-06	7.69e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.25e-06	7.68e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—colon cancer	5.24e-06	7.67e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NRAS—colon cancer	5.18e-06	7.57e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—AKT1—colon cancer	5.17e-06	7.57e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—colon cancer	5.16e-06	7.55e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NRAS—colon cancer	5.1e-06	7.46e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—AKT1—colon cancer	5.09e-06	7.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PIK3CA—colon cancer	5.05e-06	7.38e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5e-06	7.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—colon cancer	4.86e-06	7.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—AKT1—colon cancer	4.86e-06	7.11e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MYC—colon cancer	4.82e-06	7.06e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—colon cancer	4.81e-06	7.04e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKT1—colon cancer	4.77e-06	6.99e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MYC—colon cancer	4.75e-06	6.95e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—colon cancer	4.74e-06	6.93e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—colon cancer	4.72e-06	6.9e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKT1—colon cancer	4.7e-06	6.88e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCB1—colon cancer	4.7e-06	6.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—colon cancer	4.67e-06	6.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—colon cancer	4.65e-06	6.8e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TYMS—colon cancer	4.62e-06	6.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGFR3—colon cancer	4.61e-06	6.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—colon cancer	4.59e-06	6.72e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.47e-06	6.54e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KRAS—colon cancer	4.46e-06	6.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTNNB1—colon cancer	4.45e-06	6.51e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KRAS—colon cancer	4.39e-06	6.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1A—colon cancer	4.35e-06	6.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—colon cancer	4.29e-06	6.28e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APC—colon cancer	4.24e-06	6.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—NRAS—colon cancer	4.24e-06	6.2e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.16e-06	6.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—EP300—colon cancer	4.14e-06	6.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—colon cancer	4.12e-06	6.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CTNNB1—colon cancer	4.11e-06	6.01e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PIK3CA—colon cancer	4.09e-06	5.99e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCB1—colon cancer	4.07e-06	5.96e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PIK3CA—colon cancer	4.03e-06	5.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SRC—colon cancer	4.02e-06	5.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1A—colon cancer	4.01e-06	5.87e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TYMS—colon cancer	4e-06	5.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BRAF—colon cancer	3.98e-06	5.83e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—colon cancer	3.96e-06	5.79e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—colon cancer	3.9e-06	5.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NRAS—colon cancer	3.87e-06	5.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—EP300—colon cancer	3.82e-06	5.59e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—colon cancer	3.79e-06	5.54e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—colon cancer	3.73e-06	5.46e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.71e-06	5.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—SRC—colon cancer	3.71e-06	5.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—KRAS—colon cancer	3.65e-06	5.33e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCB1—colon cancer	3.63e-06	5.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NRAS—colon cancer	3.57e-06	5.23e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TYMS—colon cancer	3.57e-06	5.22e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TYMS—colon cancer	3.48e-06	5.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PIK3CA—colon cancer	3.35e-06	4.9e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—colon cancer	3.34e-06	4.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KRAS—colon cancer	3.33e-06	4.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—colon cancer	3.33e-06	4.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—colon cancer	3.32e-06	4.86e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—colon cancer	3.29e-06	4.82e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—colon cancer	3.27e-06	4.79e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—colon cancer	3.1e-06	4.53e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.08e-06	4.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—KRAS—colon cancer	3.08e-06	4.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PIK3CA—colon cancer	3.06e-06	4.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—colon cancer	2.99e-06	4.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCND1—colon cancer	2.91e-06	4.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CTNNB1—colon cancer	2.88e-06	4.21e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—colon cancer	2.83e-06	4.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—colon cancer	2.83e-06	4.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PIK3CA—colon cancer	2.83e-06	4.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1A—colon cancer	2.81e-06	4.11e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.75e-06	4.02e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—colon cancer	2.74e-06	4e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EP300—colon cancer	2.67e-06	3.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—colon cancer	2.61e-06	3.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SRC—colon cancer	2.6e-06	3.81e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—colon cancer	2.57e-06	3.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—colon cancer	2.53e-06	3.71e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—colon cancer	2.53e-06	3.7e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NRAS—colon cancer	2.5e-06	3.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—colon cancer	2.5e-06	3.66e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—colon cancer	2.47e-06	3.61e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—colon cancer	2.33e-06	3.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—colon cancer	2.33e-06	3.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—colon cancer	2.31e-06	3.38e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—colon cancer	2.23e-06	3.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCB1—colon cancer	2.19e-06	3.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KRAS—colon cancer	2.15e-06	3.15e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TYMS—colon cancer	2.15e-06	3.14e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—EP300—colon cancer	2.14e-06	3.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—colon cancer	1.99e-06	2.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3CA—colon cancer	1.98e-06	2.9e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—colon cancer	1.94e-06	2.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—colon cancer	1.91e-06	2.8e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—EP300—colon cancer	1.85e-06	2.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—colon cancer	1.83e-06	2.68e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—EP300—colon cancer	1.65e-06	2.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—colon cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—EP300—colon cancer	1.61e-06	2.36e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3CA—colon cancer	1.58e-06	2.32e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—colon cancer	1.52e-06	2.22e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3CA—colon cancer	1.37e-06	2.01e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—colon cancer	1.29e-06	1.89e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3CA—colon cancer	1.22e-06	1.79e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—colon cancer	1.2e-06	1.75e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3CA—colon cancer	1.19e-06	1.75e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—colon cancer	1.12e-06	1.64e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—colon cancer	1e-06	1.46e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—EP300—colon cancer	9.95e-07	1.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—colon cancer	9.76e-07	1.43e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3CA—colon cancer	7.36e-07	1.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—colon cancer	6.01e-07	8.8e-06	CbGpPWpGaD
